Our Products

Erlotinib Tablets 100 mg is a targeted therapy medication used primarily for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It is an epidermal growth factor receptor (EGFR) inhibitor that works by blocking the activity of the EGFR, a protein involved in the growth and spread of cancer cells. By inhibiting EGFR, Erlotinib helps slow the growth of cancer cells that depend on this receptor for survival and proliferation.

The 100 mg dosage is typically taken once daily, with or without food, as prescribed by a healthcare provider. Common side effects may include skin rash, diarrhea, nausea, loss of appetite, fatigue, and liver enzyme abnormalities. Regular monitoring of liver function and skin health is recommended during treatment to manage potential side effects and ensure the medication’s effectiveness.